UK Backs Opdivo for Lung Cancer After Bristol-Myers Cuts Price UK Backs Opdivo for Lung Cancer After Bristol-Myers Cuts Price

Bristol-Myers Squibb ' s immunotherapy drug Opdivo has been recommended for some patients with lung cancer by Britain ' s healthcare cost watchdog NICE after the drugmaker agreed a discounted price.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news